Denator's first commercial system for instant tissue stabilisation will be launched at the Hupo meeting in Amsterdam in August, 2008
Denator announced today that the company is establishing a commercial sales network in Europe and the USA.
Katarina Alenas joins Denator to become the European sales director.
Over the past ten years, Alenas has held sales, marketing and product management roles in several life science and diagnostics companies including Agilent Technologies, Bayer Healthcare Diagnositics and Aventis.
In the USA, Denator will be represented by John Lindsay, SciPartners , a sales professional with more than 25 years of proven success in the introduction of novel, leading-edge instrumentation into the life sciences market.
Olof Skold, CEO at Denator, stated: "Building up a sales organisation within the USA and Europe is our next important step in preparation for the successful commercialization of Denator's technology platform.
"So far, we have had excellent feedback from ongoing research collaborations.
"This, together with the recent decision of Professor Deelder's laboratory at the Center for Infectious Diseases, Leiden University Medical School, Belgium to invest in our technology platform, has convinced us that we are well on the way to offering a unique technology that will significantly change the approach to sample preparation, offering major benefits throughout downstream analysis".
